Saturday, September 29, 2018

Institutional Review Board Roles and Functions to Conduct #ClinicalTrials at a Medium-Sized Regional Hospital, Japan by Atsushi Imai in BJSTR


Abstract


#Clinicaltrials are a key resource for the discovery of new #diagnostic, treatment and #prevention methods for disease. Many of today’s most introduced prevention and treatment modalities are based on previous clinical trial results. Clinical trials are an important part of improving quality of health care [1]. Facilitators of participation in clinical trials have been linked to recommendations by reliable health care providers, a supportive family, satisfactory doctor-patient relationship that depends on culture, financial incentives, anticipation of a personal benefit to participants, convenience to #participants and culturally appropriate advertisements [2]. To address such facilitators and barriers of clinical trial participation in communities, we report our institutional review board (IRB) of Matsunami General Hospital [3]. A typical central medical institution anchor of the region, Japan.

https://biomedres.us/abstracts/BJSTR.MS.ID.000634.php

https://biomedres.us/pdfs/BJSTR.MS.ID.000634.pdf

https://biomedres.us/fulltexts/BJSTR.MS.ID.000634.php

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Nanomedicine and Nano Formulations for Neurodegenerative Diseases

  Nanomedicine and Nano Formulations for Neurodegenerative Diseases Introduction Neurodegenerative diseases are characterized by the progres...